Does DACLIZUMAB Cause Product use issue? 87 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 87 reports of Product use issue have been filed in association with DACLIZUMAB. This represents 3.1% of all adverse event reports for DACLIZUMAB.
87
Reports of Product use issue with DACLIZUMAB
3.1%
of all DACLIZUMAB reports
4
Deaths
3
Hospitalizations
How Dangerous Is Product use issue From DACLIZUMAB?
Of the 87 reports, 4 (4.6%) resulted in death, 3 (3.4%) required hospitalization, and 50 (57.5%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACLIZUMAB. However, 87 reports have been filed with the FAERS database.
What Other Side Effects Does DACLIZUMAB Cause?
Alopecia (450)
Transplant dysfunction (421)
Transplant rejection (385)
Acne (382)
Ovarian cyst (374)
Multiple sclerosis relapse (313)
Drug ineffective (229)
Pain (224)
Pneumonia (213)
Condition aggravated (172)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which DACLIZUMAB Alternatives Have Lower Product use issue Risk?
DACLIZUMAB vs DACOMITINIB
DACLIZUMAB vs DACTINOMYCIN
DACLIZUMAB vs DALBAVANCIN
DACLIZUMAB vs DALFAMPRIDINE
DACLIZUMAB vs DALTEPARIN